Scientists have discovered new information about the way that small molecules cause cell signalling, according to a paper to be published online in Nature Chemical Biology. This insight could have major implications in regards to how drugs are developed.
G protein-coupled receptors, or GPCRs, are major drug targets because they bind to molecules that are outside the cell, and this binding causes big changes inside the cell. This means that a potential drug doesn't have to be able to cross the cell membrane to be active, which is simplifies the design of the drug.
Jean-Pierre Vilardaga and colleagues now find that, for some GPCRs that come together in pairs, the signaling by these pairs of receptors is different than signalling by a single receptor. This result will have particular relevance for scientists developing combination drugs, as the mixing of two individual small molecules may not cause the expected biological effect.
Jean-Pierre Vilardaga (Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA)
Abstract available online.
(C) Nature Chemical Biology press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking